1 | | - | SB1238 EngrossedLRB104 09624 BDA 19689 b SB1238 Engrossed LRB104 09624 BDA 19689 b |
---|
2 | | - | SB1238 Engrossed LRB104 09624 BDA 19689 b |
---|
| 1 | + | 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1238 Introduced 1/24/2025, by Sen. Karina Villa SYNOPSIS AS INTRODUCED: 20 ILCS 2310/2310-735 new215 ILCS 5/370c.3 new305 ILCS 5/5-58 new Creates the Nonopioid Alternatives for Pain Act. Allows the Department of Public Health to develop and publish on its website a nonopioid alternatives pamphlet, with certain requirements. Prohibits a health insurance issuer to deny coverage of a nonopioid prescription drug in favor of an opioid prescription drug. Amends the Illinois Public Aid Code. Provides that coverage shall not be denied for a nonopioid prescription drug in favor of an opioid prescription drug. Requires that nonopioid drugs preferred on a specific list for the treatment or management of pain shall not be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of pain. Effective July 1, 2027. LRB104 09624 BDA 19689 b A BILL FOR 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1238 Introduced 1/24/2025, by Sen. Karina Villa SYNOPSIS AS INTRODUCED: 20 ILCS 2310/2310-735 new215 ILCS 5/370c.3 new305 ILCS 5/5-58 new 20 ILCS 2310/2310-735 new 215 ILCS 5/370c.3 new 305 ILCS 5/5-58 new Creates the Nonopioid Alternatives for Pain Act. Allows the Department of Public Health to develop and publish on its website a nonopioid alternatives pamphlet, with certain requirements. Prohibits a health insurance issuer to deny coverage of a nonopioid prescription drug in favor of an opioid prescription drug. Amends the Illinois Public Aid Code. Provides that coverage shall not be denied for a nonopioid prescription drug in favor of an opioid prescription drug. Requires that nonopioid drugs preferred on a specific list for the treatment or management of pain shall not be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of pain. Effective July 1, 2027. LRB104 09624 BDA 19689 b LRB104 09624 BDA 19689 b A BILL FOR |
---|
| 2 | + | 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1238 Introduced 1/24/2025, by Sen. Karina Villa SYNOPSIS AS INTRODUCED: |
---|
| 3 | + | 20 ILCS 2310/2310-735 new215 ILCS 5/370c.3 new305 ILCS 5/5-58 new 20 ILCS 2310/2310-735 new 215 ILCS 5/370c.3 new 305 ILCS 5/5-58 new |
---|
| 4 | + | 20 ILCS 2310/2310-735 new |
---|
| 5 | + | 215 ILCS 5/370c.3 new |
---|
| 6 | + | 305 ILCS 5/5-58 new |
---|
| 7 | + | Creates the Nonopioid Alternatives for Pain Act. Allows the Department of Public Health to develop and publish on its website a nonopioid alternatives pamphlet, with certain requirements. Prohibits a health insurance issuer to deny coverage of a nonopioid prescription drug in favor of an opioid prescription drug. Amends the Illinois Public Aid Code. Provides that coverage shall not be denied for a nonopioid prescription drug in favor of an opioid prescription drug. Requires that nonopioid drugs preferred on a specific list for the treatment or management of pain shall not be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of pain. Effective July 1, 2027. |
---|
| 8 | + | LRB104 09624 BDA 19689 b LRB104 09624 BDA 19689 b |
---|
| 9 | + | LRB104 09624 BDA 19689 b |
---|
| 10 | + | A BILL FOR |
---|
| 11 | + | SB1238LRB104 09624 BDA 19689 b SB1238 LRB104 09624 BDA 19689 b |
---|
| 12 | + | SB1238 LRB104 09624 BDA 19689 b |
---|
28 | | - | SB1238 Engrossed LRB104 09624 BDA 19689 b |
---|
29 | | - | |
---|
30 | | - | |
---|
31 | | - | SB1238 Engrossed- 2 -LRB104 09624 BDA 19689 b SB1238 Engrossed - 2 - LRB104 09624 BDA 19689 b |
---|
32 | | - | SB1238 Engrossed - 2 - LRB104 09624 BDA 19689 b |
---|
33 | | - | 1 adding Section 370c.3 as follows: |
---|
34 | | - | 2 (215 ILCS 5/370c.3 new) |
---|
35 | | - | 3 Sec. 370c.3. Parity for coverage for nonopioid medications |
---|
36 | | - | 4 to treat acute pain. |
---|
37 | | - | 5 (a) Beginning January 1, 2027, a health insurance issuer |
---|
38 | | - | 6 shall develop a plan to provide adequate coverage and access |
---|
39 | | - | 7 to a broad spectrum of pain management services, including, |
---|
40 | | - | 8 but not limited to, nonopioid, nonnarcotic pain management |
---|
41 | | - | 9 services and non-medication pain management services that |
---|
42 | | - | 10 serve as alternatives to the prescribing of opioid or narcotic |
---|
43 | | - | 11 drugs in accordance with guidelines developed by the |
---|
44 | | - | 12 Department of Insurance. |
---|
45 | | - | 13 (b) A health insurance issuer shall file the plan required |
---|
46 | | - | 14 under subsection (a) with the Department of Insurance and |
---|
47 | | - | 15 shall post information about the pain management plan on the |
---|
48 | | - | 16 insurer's publicly accessible website. |
---|
49 | | - | 17 Section 15. The Illinois Public Aid Code is amended by |
---|
50 | | - | 18 adding Section 5-58 as follows: |
---|
51 | | - | 19 (305 ILCS 5/5-58 new) |
---|
52 | | - | 20 Sec. 5-58. Illinois Medicaid Preferred Drug List; |
---|
53 | | - | 21 nonopioid drugs. In establishing and maintaining the Illinois |
---|
54 | | - | 22 Medicaid Preferred Drug List as described in Section 5-30.14, |
---|
55 | | - | 23 the Department shall ensure that nonopioid drugs on the |
---|
| 38 | + | 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1238 Introduced 1/24/2025, by Sen. Karina Villa SYNOPSIS AS INTRODUCED: |
---|
| 39 | + | 20 ILCS 2310/2310-735 new215 ILCS 5/370c.3 new305 ILCS 5/5-58 new 20 ILCS 2310/2310-735 new 215 ILCS 5/370c.3 new 305 ILCS 5/5-58 new |
---|
| 40 | + | 20 ILCS 2310/2310-735 new |
---|
| 41 | + | 215 ILCS 5/370c.3 new |
---|
| 42 | + | 305 ILCS 5/5-58 new |
---|
| 43 | + | Creates the Nonopioid Alternatives for Pain Act. Allows the Department of Public Health to develop and publish on its website a nonopioid alternatives pamphlet, with certain requirements. Prohibits a health insurance issuer to deny coverage of a nonopioid prescription drug in favor of an opioid prescription drug. Amends the Illinois Public Aid Code. Provides that coverage shall not be denied for a nonopioid prescription drug in favor of an opioid prescription drug. Requires that nonopioid drugs preferred on a specific list for the treatment or management of pain shall not be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of pain. Effective July 1, 2027. |
---|
| 44 | + | LRB104 09624 BDA 19689 b LRB104 09624 BDA 19689 b |
---|
| 45 | + | LRB104 09624 BDA 19689 b |
---|
| 46 | + | A BILL FOR |
---|
81 | | - | SB1238 Engrossed - 3 - LRB104 09624 BDA 19689 b |
---|
| 64 | + | |
---|
| 65 | + | |
---|
| 66 | + | |
---|
| 67 | + | |
---|
| 68 | + | SB1238 LRB104 09624 BDA 19689 b |
---|
| 69 | + | |
---|
| 70 | + | |
---|
| 71 | + | SB1238- 2 -LRB104 09624 BDA 19689 b SB1238 - 2 - LRB104 09624 BDA 19689 b |
---|
| 72 | + | SB1238 - 2 - LRB104 09624 BDA 19689 b |
---|
| 73 | + | 1 adding Sections 370c.3 as follows: |
---|
| 74 | + | 2 (215 ILCS 5/370c.3 new) |
---|
| 75 | + | 3 Sec. 370c.3. Coverage for nonopioid medications; pain |
---|
| 76 | + | 4 relief parity. |
---|
| 77 | + | 5 (a) In this Section, "health insurance issuer" has the |
---|
| 78 | + | 6 meaning set forth in Section 5 of the Illinois Health |
---|
| 79 | + | 7 Insurance Portability and Accountability Act. |
---|
| 80 | + | 8 (b) Notwithstanding any provision of law to the contrary, |
---|
| 81 | + | 9 when a licensed health care practitioner prescribes a |
---|
| 82 | + | 10 nonopioid medication for the treatment of acute pain, it shall |
---|
| 83 | + | 11 be unlawful for a health insurance issuer to deny coverage of |
---|
| 84 | + | 12 the nonopioid prescription drug in favor of an opioid |
---|
| 85 | + | 13 prescription drug or to require the patient to try an opioid |
---|
| 86 | + | 14 prescription drug prior to providing coverage of the nonopioid |
---|
| 87 | + | 15 prescription drug. |
---|
| 88 | + | 16 (c) In establishing and maintaining its drug formulary, a |
---|
| 89 | + | 17 health insurance issuer shall ensure that no nonopioid drug |
---|
| 90 | + | 18 approved by the United States Food and Drug Administration for |
---|
| 91 | + | 19 the treatment or management of pain shall be disadvantaged or |
---|
| 92 | + | 20 discouraged, with respect to coverage or cost sharing, |
---|
| 93 | + | 21 relative to any opioid or narcotic drug for the treatment or |
---|
| 94 | + | 22 management of pain on the health insurance issuer's drug |
---|
| 95 | + | 23 formulary, where impermissible disadvantaging or |
---|
| 96 | + | 24 discouragement includes, without limitation: imposing more |
---|
| 97 | + | 25 restrictive coverage criteria on any such nonopioid drug than |
---|
| 98 | + | |
---|
| 99 | + | |
---|
| 100 | + | |
---|
| 101 | + | |
---|
| 102 | + | |
---|
| 103 | + | SB1238 - 2 - LRB104 09624 BDA 19689 b |
---|
| 104 | + | |
---|
| 105 | + | |
---|
| 106 | + | SB1238- 3 -LRB104 09624 BDA 19689 b SB1238 - 3 - LRB104 09624 BDA 19689 b |
---|
| 107 | + | SB1238 - 3 - LRB104 09624 BDA 19689 b |
---|
| 108 | + | 1 the least restrictive coverage criteria imposed on an opioid |
---|
| 109 | + | 2 or narcotic drug; establishing more restrictive or more |
---|
| 110 | + | 3 extensive utilization controls, including, but not limited to, |
---|
| 111 | + | 4 more restrictive or more extensive prior authorization or step |
---|
| 112 | + | 5 therapy requirements, for such nonopioid drug than the least |
---|
| 113 | + | 6 restrictive or extensive utilization controls applicable to |
---|
| 114 | + | 7 any such opioid or narcotic drug; or, if the health insurance |
---|
| 115 | + | 8 issuer maintains a drug formulary grouped into tiers for the |
---|
| 116 | + | 9 purposes of determining cost sharing, placing any such |
---|
| 117 | + | 10 nonopioid drug on a tier that requires a cost-sharing |
---|
| 118 | + | 11 responsibility that exceeds the lowest cost-sharing |
---|
| 119 | + | 12 responsibility required for any opioid or narcotic drug on the |
---|
| 120 | + | 13 drug formulary. This subsection does not preclude opioid drugs |
---|
| 121 | + | 14 from being preferred over other opioid drugs or nonopioid |
---|
| 122 | + | 15 drugs from being preferred over other nonopioid drugs. |
---|
| 123 | + | 16 Section 15. The Illinois Public Aid Code is amended by |
---|
| 124 | + | 17 adding Section 5-58 as follows: |
---|
| 125 | + | 18 (305 ILCS 5/5-58 new) |
---|
| 126 | + | 19 Sec. 5-58. Coverage for nonopioid medications; pain relief |
---|
| 127 | + | 20 parity. |
---|
| 128 | + | 21 (a) Required coverage for nonopioid medications. |
---|
| 129 | + | 22 Notwithstanding any provision of law to the contrary, whenever |
---|
| 130 | + | 23 a licensed health care practitioner prescribes a nonopioid |
---|
| 131 | + | 24 medication for the treatment of acute pain, neither the |
---|
| 132 | + | |
---|
| 133 | + | |
---|
| 134 | + | |
---|
| 135 | + | |
---|
| 136 | + | |
---|
| 137 | + | SB1238 - 3 - LRB104 09624 BDA 19689 b |
---|
| 138 | + | |
---|
| 139 | + | |
---|
| 140 | + | SB1238- 4 -LRB104 09624 BDA 19689 b SB1238 - 4 - LRB104 09624 BDA 19689 b |
---|
| 141 | + | SB1238 - 4 - LRB104 09624 BDA 19689 b |
---|
| 142 | + | 1 Department nor a managed care organization contracted with the |
---|
| 143 | + | 2 Department shall deny coverage of the nonopioid prescription |
---|
| 144 | + | 3 drug in favor of an opioid prescription drug or require a |
---|
| 145 | + | 4 patient to try an opioid prescription drug prior to providing |
---|
| 146 | + | 5 coverage of the nonopioid prescription drug. |
---|
| 147 | + | 6 (b) Pain relief parity. In establishing and maintaining |
---|
| 148 | + | 7 the Illinois Medicaid Preferred Drug List, the Department |
---|
| 149 | + | 8 shall ensure that nonopioid drugs preferred on the |
---|
| 150 | + | 9 Department's preferred drug list, and approved by the U.S. |
---|
| 151 | + | 10 Food and Drug Administration, for the treatment or management |
---|
| 152 | + | 11 of pain shall not be disadvantaged or discouraged with respect |
---|
| 153 | + | 12 to coverage relative to any opioid or narcotic drug for the |
---|
| 154 | + | 13 treatment or management of pain. |
---|
| 155 | + | |
---|
| 156 | + | |
---|
| 157 | + | |
---|
| 158 | + | |
---|
| 159 | + | |
---|
| 160 | + | SB1238 - 4 - LRB104 09624 BDA 19689 b |
---|